Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Feb;83(2):187-91.
doi: 10.1111/j.1365-2249.1991.tb05612.x.

A subset of gamma delta lymphocytes is increased during HIV-1 infection

Affiliations

A subset of gamma delta lymphocytes is increased during HIV-1 infection

P De Paoli et al. Clin Exp Immunol. 1991 Feb.

Abstract

The gamma delta T cell receptor (TcR) lymphocytes constitute 3-10% of human peripheral blood lymphocytes. Only a very small fraction of these cells is recognized by the delta TCS1 monoclonal antibody, directed against the V delta 1 chain of the receptor. We describe the immunological, virological and clinical data of a small group of seropositive subjects having high levels of gamma delta TcR T cells in the peripheral blood. Our flow cytometric studies show that most of these cells belong to the delta TCS1+ (V delta 1+), CD8 +/- (dim staining) subset. Patients with high gamma delta TcR T cell numbers were not characterized by the presence of an acute (IgM positive) or reactivated (as defined by high IgG titres against early antigen or IgA titres against viral capsidic antigen) Epstein-Barr virus infection. Cytomegalovirus infection was excluded by serological assays, and other herpes viral infections were not found after clinical examination. HIV p24 antigenaemia was present in two out of 11 subjects. AIDS patients had very high percentages of gamma delta TcR T cells. Altogether these data show that the selective expansion of delta TCS1+ cells in HIV1 seropositive subjects is not related to some exogenous antigen stimulation, but may be related to peculiar pathologic processes involving the immune system.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1990 Jan 11;322(2):73-6 - PubMed
    1. J Infect Dis. 1990 May;161(5):1013-6 - PubMed
    1. Int J Cancer. 1986 Jul 15;38(1):55-9 - PubMed
    1. Eur J Immunol. 1988 Dec;18(12):1985-92 - PubMed
    1. Clin Exp Immunol. 1988 Dec;74(3):317-20 - PubMed

MeSH terms

Substances